The consumption of some dietary supplements, herbal treatments, and some medications may also lead to cardiac arrhythmia. Thus, one of the successful treatments that follow to treat such conditions is cardiac ablation.
As per the Centers for Disease Control and Prevention (CDC), in 2020, the risk for atrial fibrillation increases with age. High blood pressure, the risk for which also increases with advancing age, accounts for about 1 in 5 cases of atrial fibrillation.
Get detailed information @ Cardiac Ablation Devices Market Forecast
It is predicted that the rising number of elderly patients would transform healthcare delivery and create a larger demand for Cardiac Ablation Devices. As per the recent survey, Global Population Aging 2020 Report (United Nations, 2020), the aging population tends to grow at an alarming pace. In 2020, there were around 727 million individuals in the world aged 65 years or older. By 2050, the figure for such patients is expected to double and reach 1.5 billion by 2050. Furthermore, as per the Centers for Disease Control and Prevention (CDC), in 2020, the risk for AFib increases with age. High blood pressure, the risk for which also increases with advancing age, accounts for about 1 in 5 cases of AFib. Thus, all these factors are projected to drive the growth of the Global Market for Cardiac Ablation Devices.
Moreover, the Cardiac Ablation Devices Market Companies are increasing their manufacturing of essential medical devices products. For instance, in August 2021, Acutus Medical, Inc. announced its innovative suite of software upgrades, known collectively as AcQMap 8, which has received FDA clearance and been awarded, CE Mark.
AcQMap 8 introduces advanced new mapping algorithms into Acutus’ foundational technology, the AcQMap 3D imaging, and mapping system. These algorithms – including AcQTrack™ and the SlowZone™ Locator (Composite Maps) – are designed to quickly highlight regions of interest during the mapping and ablation of complex atrial arrhythmias, the treatment of which has been shown to significantly improve patient outcomes.
Therefore, such initiatives are expected to help the market and the patients in their treatment will drive the Global Cardiac Ablation Devices market growth also.
However, the product recalls and unfavourable regulatory scenarios may prove to be certain restraints to the Global Cardiac Ablation Devices market growth. Thus, the high prevalence of cardiovascular diseases that majorly includes heart failure conditions rising across the globe to which Cardiac Ablation Devices have emerged as potential solutions for patients' treatment and are likely to boost the growth of the device market.